ALBUQUERQUE, N.M. — A Las Cruces, New Mexico, woman is suing the makers and distributors of NuvaRing, citing alleged negligent misrepresentation and breach of implied warranty.

Tammara Chaffee filed a complaint on May 11 in the U.S. District Court District of New Mexico against Organon USA Inc., N.V. Organon, Schering Corp., Merck and Co. Inc. and Merck Sharp and Dohme alleging that the defendants failed to properly disclose the known safety hazards associated with the contraceptive NuvaRing.

This is a potential tag-along action that should be transferred to the U.S. District Court for the Eastern District of Missouri to be included in a NuvaRing products liability case, according to court documents

According to the complaint, the plaintiff alleges that on June 10, 2014, the plaintiff claims she began to experience chest pain and shortness of breath. After visiting Mountain View Regional Medical Center, she was advised to discontinue the use of the NuvaRing because of pulmonary embolism and was immediately placed on Lovenox anticoagulation therapy. As a result, Chaffee claims she suffered excruciating pain and medical expenses. 

The plaintiff alleges the defendants failed to warn consumers of the serious risks of the product, failed to conduct appropriate testing prior to the NuvaRing being prescribed to consumers and failed to provide proper and full information about the safety of the product to the Food and Drug Administration.

The plaintiff requests a trial by jury and seeks judgment in excess of $75,000 for all damages caused, expenses, costs of this action and such further relief as the court deems necessary, just and proper. She is represented by Bryan Williams of Ron Bell Injury Lawyers in Albuquerque and David B. Krangle and Andres F. Alonso of Alonso Krangle LLP in Melville, New York.

U.S. District Court District of New Mexico case number 4:17-cv-01575-RWS

More News